Clinical Trials Logo

Surgical Wound, Recent clinical trials

View clinical trials related to Surgical Wound, Recent.

Filter by:
  • None
  • Page 1

NCT ID: NCT05805046 Withdrawn - Clinical trials for Trauma-related Wound

Study of Avelle™ Negative Pressure Wound Therapy (NPWT) System

Start date: September 30, 2023
Phase:
Study type: Observational

The main questions the study aims to answer are: - How much do wounds improve when using the Avelle™ Negative Pressure Wound Therapy System for a maximum of 14 days? - How safe is the Avelle™ Negative Pressure Wound Therapy System?

NCT ID: NCT04894604 Not yet recruiting - Surgical Wound Clinical Trials

A Safety and Performance PMCF Investigation of the Avance® Solo NPWT System in Surgically Closed Incisions

ASOLO-SCI
Start date: June 30, 2021
Phase: N/A
Study type: Interventional

The ASOLO-SCI investigation is a Post Market Clinical Follow-up (PMCF) study to investigate the safety and performance of the Avance® Solo NPWT System in treating low to moderate exuding surgically closed incisions for up to 14 days when used in accordance with the Instructions for Use (IfU).

NCT ID: NCT03199911 Completed - Clinical trials for Surgical Site Infection

Topical Antibiotic Prophylaxis for Eyelids

Start date: October 2, 2017
Phase: Phase 4
Study type: Interventional

The investigators propose a prospective randomized control trial testing the hypothesis that routine topical antibiotic prophylaxis does not significantly reduce the rate of infection after eyelid surgery.

NCT ID: NCT01417234 Completed - Clinical trials for Trauma-related Wound

Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System for Treatment of Acute Trauma and Acute Surgical Excision Wounds

Start date: June 2011
Phase:
Study type: Observational

The purpose of this study is to evaluate the efficacy of the Spiracur SNaP® Wound Care System for the treatment of acute trauma and acute surgical excision wounds. The secondary purpose will be to compare the prospective patients to retrospectively treated acute trauma wounds to further evaluate efficacy and safety.